SG11202111162PA - Pyridin-3-yl derivatives - Google Patents
Pyridin-3-yl derivativesInfo
- Publication number
- SG11202111162PA SG11202111162PA SG11202111162PA SG11202111162PA SG11202111162PA SG 11202111162P A SG11202111162P A SG 11202111162PA SG 11202111162P A SG11202111162P A SG 11202111162PA SG 11202111162P A SG11202111162P A SG 11202111162PA SG 11202111162P A SG11202111162P A SG 11202111162PA
- Authority
- SG
- Singapore
- Prior art keywords
- pyridin
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2019065963 | 2019-06-18 | ||
| PCT/EP2020/066767 WO2020254408A1 (fr) | 2019-06-18 | 2020-06-17 | Dérivés de pyridin-3-yle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202111162PA true SG11202111162PA (en) | 2021-11-29 |
Family
ID=71105482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202111162PA SG11202111162PA (en) | 2019-06-18 | 2020-06-17 | Pyridin-3-yl derivatives |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220251068A1 (fr) |
| EP (1) | EP3986884A1 (fr) |
| JP (1) | JP7494222B2 (fr) |
| KR (1) | KR20220020921A (fr) |
| CN (1) | CN114026082B (fr) |
| AR (1) | AR119162A1 (fr) |
| AU (1) | AU2020298014A1 (fr) |
| BR (1) | BR112021025236A2 (fr) |
| CA (1) | CA3143618A1 (fr) |
| CL (1) | CL2021003348A1 (fr) |
| IL (1) | IL288950A (fr) |
| MA (1) | MA56504A (fr) |
| MX (1) | MX2021015727A (fr) |
| SG (1) | SG11202111162PA (fr) |
| WO (1) | WO2020254408A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114761001A (zh) * | 2019-12-04 | 2022-07-15 | 爱杜西亚药品有限公司 | 氮杂环丁烷lpa1受体拮抗剂与抗纤维化药剂的组合 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1364659B1 (fr) | 2001-02-08 | 2009-11-11 | Ono Pharmaceutical Co., Ltd. | Remedes pour des maladies urinaires contenant des agents de regulation du recepteur de lpa |
| TW200403058A (en) * | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
| US20070078120A1 (en) | 2003-10-21 | 2007-04-05 | Hitoshi Ban | Novel piperidine derivative |
| AU2004289290A1 (en) | 2003-11-12 | 2005-05-26 | Merck & Co., Inc. | 4-phenyl piperdine sulfonyl glycine transporter inhibitors |
| CA2546339A1 (fr) | 2003-11-18 | 2005-06-02 | Warner-Lambert Company Llc | Derives antibacteriens d'aminoquinazolidinedione |
| NZ566793A (en) | 2005-08-24 | 2010-03-26 | Eisai R&D Man Co Ltd | Novel pyridine derivative and pyrimidine derivative |
| JP5164510B2 (ja) | 2006-10-06 | 2013-03-21 | 日本曹達株式会社 | 含窒素複素環化合物および有害生物防除剤 |
| AU2008311971A1 (en) | 2007-10-18 | 2009-04-23 | Merck Sharp & Dohme Corp. | Quinolizidinone M1 receptor positive allosteric modulators |
| JP5785491B2 (ja) | 2008-05-05 | 2015-09-30 | サノフイ | アシルアミノ置換縮合シクロペンタンカルボン酸誘導体及び医薬としてのその使用 |
| BR112012006686B8 (pt) | 2009-09-25 | 2021-05-25 | Astellas Pharma Inc | compostos de amida substituída, composições farmacêuticas contendo os ditos compostos, e uso dos mesmos para prevenir e/ou tratar doenças causadas pelo lpa |
| KR101508862B1 (ko) | 2010-08-05 | 2015-04-07 | 조에티스 엘엘씨 | 구충제로서 이속사졸린 유도체 |
| TW201305178A (zh) | 2010-10-29 | 2013-02-01 | Glenmark Pharmaceuticals Sa | 作為ｍＰＧＥＳ－１抑制物的三環化合物 |
| EP3360552A1 (fr) | 2010-12-07 | 2018-08-15 | Amira Pharmaceuticals, Inc. | Antagoniste lpa1 polycyclique et utilisations de celui-ci |
| CA2828397C (fr) | 2011-03-10 | 2015-10-13 | Zoetis Llc | Derives d'isoxazolines spirocycliques a titre d'agents antiparasitaires |
| AU2012358359A1 (en) | 2011-12-21 | 2014-07-24 | Ardelyx, Inc. | Non-systemic TGR5 agonists |
| CN105189481A (zh) * | 2013-03-13 | 2015-12-23 | 艾伯维公司 | 吡啶cdk9激酶抑制剂 |
| WO2015069593A1 (fr) | 2013-11-06 | 2015-05-14 | Bristol-Myers Squibb Company | Dérivés de pyridine substitués utiles en tant qu'agonistes de gsk-3 |
| CN112236424B (zh) * | 2018-06-07 | 2024-03-15 | 爱杜西亚药品有限公司 | 经烷氧基取代的吡啶基衍生物 |
-
2020
- 2020-06-16 AR ARP200101686A patent/AR119162A1/es unknown
- 2020-06-17 JP JP2021574814A patent/JP7494222B2/ja active Active
- 2020-06-17 MX MX2021015727A patent/MX2021015727A/es unknown
- 2020-06-17 US US17/620,520 patent/US20220251068A1/en active Pending
- 2020-06-17 BR BR112021025236A patent/BR112021025236A2/pt unknown
- 2020-06-17 CN CN202080044333.8A patent/CN114026082B/zh active Active
- 2020-06-17 AU AU2020298014A patent/AU2020298014A1/en active Pending
- 2020-06-17 EP EP20733601.7A patent/EP3986884A1/fr active Pending
- 2020-06-17 KR KR1020227001133A patent/KR20220020921A/ko not_active Application Discontinuation
- 2020-06-17 MA MA056504A patent/MA56504A/fr unknown
- 2020-06-17 CA CA3143618A patent/CA3143618A1/fr active Pending
- 2020-06-17 SG SG11202111162PA patent/SG11202111162PA/en unknown
- 2020-06-17 WO PCT/EP2020/066767 patent/WO2020254408A1/fr unknown
-
2021
- 2021-12-13 IL IL288950A patent/IL288950A/en unknown
- 2021-12-15 CL CL2021003348A patent/CL2021003348A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA56504A (fr) | 2022-04-27 |
| US20220251068A1 (en) | 2022-08-11 |
| EP3986884A1 (fr) | 2022-04-27 |
| CL2021003348A1 (es) | 2022-09-23 |
| WO2020254408A1 (fr) | 2020-12-24 |
| JP2022537177A (ja) | 2022-08-24 |
| CN114026082A (zh) | 2022-02-08 |
| TW202115011A (zh) | 2021-04-16 |
| IL288950A (en) | 2022-02-01 |
| CA3143618A1 (fr) | 2020-12-24 |
| CN114026082B (zh) | 2024-06-07 |
| JP7494222B2 (ja) | 2024-06-03 |
| AR119162A1 (es) | 2021-12-01 |
| KR20220020921A (ko) | 2022-02-21 |
| BR112021025236A2 (pt) | 2022-02-01 |
| AU2020298014A1 (en) | 2022-02-10 |
| MX2021015727A (es) | 2022-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286846A (en) | History of camptothecin | |
| IL271607B1 (en) | New azaquinoline histories | |
| ZA202204675B (en) | New methylquinazolinone derivatives | |
| IL283197A (en) | Biocidal 2-acylamino-thiazole-4-carboxamide derivatives | |
| IL283990A (en) | Modified oxopyridine derivatives | |
| IL289197A (en) | History of 2-hydroxycycloalkane-1-carbamoyl | |
| SG11202010024UA (en) | New quinoline derivatives | |
| IL279938A (en) | History of spirochroman | |
| IL290964A (en) | A 2-aminoquinazolinone derivative | |
| ZA202106024B (en) | Heterocyclic derivatives | |
| IL290815A (en) | History of alpha-d-galactopyranoside | |
| HUE064831T2 (hu) | Szulfonil-amino-benzamid származékok | |
| IL271290A (en) | Dihydro-pyrrolo-pyridine derivatives | |
| IL288950A (en) | History of pyridine-3-yl | |
| PL3770162T3 (pl) | Pochodne dihydrochromenu | |
| SG11202006837XA (en) | Dihydroindolizinone derivative | |
| GB201919210D0 (en) | Dihydro-cyclopenta-isoquinoline derivatives | |
| GB201806948D0 (en) | Derivatives | |
| GB201919213D0 (en) | Dihydrocyclopenta-Isoquinoline-Sulfanamide derivatives compounds | |
| IL304189A (en) | Pyrazolamide derivatives | |
| GB201917052D0 (en) | Bioselection approach |